Schedule-Dependent Toxicity of Tumor Necrosis Factor in Rodents
- 1 January 1987
- journal article
- research article
- Published by Mary Ann Liebert Inc in Cancer Drug Delivery
- Vol. 4 (3) , 159-167
- https://doi.org/10.1089/cdd.1987.4.159
Abstract
The effect of recombinant human tumor necrosis factor-alpha (rhTNF-.alpha.) on rodent hematopoietic precursors and hepatocytes was evaluated. rhTNF-.alpha. appears to have minimal toxic effects on isolated hepatocytes and on granulocyte-macrophage colony-forming units (CFU-GM) in vitro. It does, however, show a dose- and schedule-dependent inhibition of pluripotent bone marrow stem cells in mice. This was most evident with prolonged continuous infusion schedules. In contrast, single daily injections of rhTNF-.alpha. did not depress bone marrow or peripheral blood counts, although slight elevations in hepatic enzyme levels were apparent. These studies suggest that continuous infusions of rhTNF-.alpha. in man may produce enhanced bone marrow suppression over equivalent bolus doses.This publication has 18 references indexed in Scilit:
- Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors.Journal of Biological Chemistry, 1986
- Cachectin and tumour necrosis factor as two sides of the same biological coinNature, 1986
- Recombinant human tumor necrosis factor — I. Cytotoxic activity in vitroInternational Journal of Immunopharmacology, 1986
- Ccl4-Induced Toxicity in Isolated Hepatocytes: the Importance of Direct Solvent InjuryHepatology, 1986
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- Identity of tumour necrosis factor and the macrophage-secreted factor cachectinNature, 1985
- Molecular Cloning of the Complementary DNA for Human Tumor Necrosis FactorScience, 1985
- Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude miceInternational Journal of Cancer, 1984
- In-use evaluation of the omnicon automated tumor colony counterCytometry, 1983
- Hematopoietic Stem CellsNew England Journal of Medicine, 1979